From: Effect of glycemic control on soluble RAGE and oxidative stress in type 2 diabetic patients
Parameter | Control healthy subjects (C) (20) | Good controlled diabetic patients (GCD) (28) | Poorly controlled diabetic patients (PCD) (42) |
---|---|---|---|
Sex (M/F) | 8/12 | 13/15 | 10/32 |
Age (years) | 51.25 ± 1.51 | 56.39 ± 1.43 | 54.00 ± 1.17 |
BMI (kg/m2) | 30.00 ± 0.82 | 31.72 ± 0.77 | 32.02 ± 0.52 |
Duration of diabetes (years) | — | 7.82 ± 0.76 | 10.48 ± 1.01 |
SBP (mmHg) | 120 ± 2 | 129 ± 2a | 130 ± 2a |
DBP (mmHg) | 78 ± 1 | 82 ± 1a | 81 ± 1a |
FPG (mg/dl) | 79.50 ± 3.07 | 155.11 ± 13.01a | 191.02 ± 13.04a |
HbA1c (%) | 5.26 ± 0.08 | 6.15 ± 0.10a | 8.71 ± 0.57a,b |
C-peptide (ng/ml) | 4.09 ± 0.30 | 4.46 ± 0.25 | 4.13 ± 0.24 |
sRAGE (pg/ml) | 804.92 ± 58.14 | 630.47 ± 48.14 | 600.06 ± 37.75a |
VCAM-1 (ng/ml) | 636.81 ± 30.33 | 739.69 ± 32.26 | 808.84 ± 36.90a |
SOD (U/ml) | 5.28 ± 0.40 | 7.44 ± 0.67 | 6.77 ± 0.61 |
NOx (μmol/l) | 177.08 ± 3.81 | 178.65 ± 4.04 | 187.15 ± 2.84 |
Ox-LDL (ng/ml) | 94.67 ± 4.28 | 96.78 ± 6.59 | 114.31 ± 8.05 |
GSH (mg/dl) | 45.81 ± 1.01 | 41.10 ± 1.34a | 39.57 ± 0.98a |
Antihypertensive therapy, n (%) | — | 12(43) | 22(52) |